TELOMERASE EXPRESSION SHOWS DIFFERENCES ACROSS MULTIPLE REGIONS OF OLIGODENDROGLIOMA VERSUS HIGH-GRADE ASTROCYTOMAS BUT SHOWS CORRELATION WITH MIB-1 LABELING
Bk. Kleinschmidtdemasters et al., TELOMERASE EXPRESSION SHOWS DIFFERENCES ACROSS MULTIPLE REGIONS OF OLIGODENDROGLIOMA VERSUS HIGH-GRADE ASTROCYTOMAS BUT SHOWS CORRELATION WITH MIB-1 LABELING, Journal of Clinical Pathology, 51(4), 1998, pp. 284-293
Aims/Background-Telomerase is an enzyme that is expressed in most huma
n neoplasms and is associated with tumour immortality. Determination o
f the point in neoplastic transformation at which telomerase is expres
sed may aid the understanding of tumour pathogenesis and progression.
Despite numerous reports on telomerase, few studies have investigated
its expression in high grade glial tumours. These studies, performed o
n archival banked, single brain tumour specimens, have shown conflicti
ng results for oligodendrogliomas and unexpectedly negative results fo
r telomerase expression in high grade astrocytomas, with one third to
one half of glioblastoma multiformes being negative. Methods-34 rapidl
y banked glioma specimens taken from patients undergoing gross total s
urgical resection of their tumours were studied. Telomerase expression
was assessed across 3-8 sampled regions from each tumour by the telom
eric repeat amplification protocol (TRAP) assay. Matched mirror image
tissue samples were taken for histological analysis of tissue adequacy
, statistical correlation of telomerase with tumour histological featu
res, Mib-1 (a marker for cell cycling) labelling, and p53 immunohistoc
hemistry. Results-All five well differentiated oligodendrogliomas were
homogeneously telomerase negative and two of three untreated anaplast
ic oligodendrogliomas were homogeneously positive. In contrast, 10 of
14 high grade astrocytomas showed heterogeneity for telomerase express
ion across the multiple regions sampled. All glioblastoma multiformes
and two of three anaplastic astrocytomas showed at least one region po
sitive for telomerase. When test samples were individually assessed in
both oligodendrogliomas and high grade astrocytomas, telomerase expre
ssion was associated with Mib-1 labelling (p < 0.001). For the entire
group, telomerase expression was associated with grade of tumour, age
of patient, and (all p < 0.001). Conclusions-This regional study clari
fies that all glioblastoma multiformes are at least focally positive a
nd that telomerase expression correlates with tumour grade in oligoden
drogliomas. Homogeneity versus heterogeneity for telomerase expression
across multiple regions of oligodendrogliomas versus high grade astro
cytomas may provide important preclinical data on the use of antitelom
erase agents in these adult glial tumours.